Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia
· Delayed Price · Currency is AUD 0.615
+0.055 (9.82%)
Feb 21, 2025, 4:10 PM AEST
ASX:PAR Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 17.82 | 56.33 | 39.67 | 71.03 | 103.92 | Upgrade
|
| Short-Term Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.75 | Upgrade
|
| Cash & Short-Term Investments | 17.87 | 56.38 | 39.72 | 71.08 | 104.67 | Upgrade
|
| Cash Growth | -68.31% | 41.94% | -44.12% | -32.09% | 32.77% | Upgrade
|
| Accounts Receivable | - | - | - | 0.02 | - | Upgrade
|
| Other Receivables | 5.08 | 6.81 | 6.72 | 8.49 | 3.51 | Upgrade
|
| Receivables | 5.08 | 6.81 | 6.72 | 8.51 | 3.51 | Upgrade
|
| Prepaid Expenses | 1.3 | 0.6 | 0.73 | 1.39 | 0.19 | Upgrade
|
| Total Current Assets | 24.25 | 63.79 | 47.17 | 80.98 | 108.37 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.34 | 0.57 | 0.76 | 0.94 | Upgrade
|
| Other Intangible Assets | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.1 | 0.1 | Upgrade
|
| Total Assets | 27.39 | 67.07 | 50.69 | 84.79 | 112.36 | Upgrade
|
| Accounts Payable | 2.82 | 12.16 | 7.09 | 4.99 | 2.75 | Upgrade
|
| Accrued Expenses | 0.42 | 0.78 | 0.59 | 0.67 | 0.46 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.04 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.1 | 0.15 | 0.13 | 0.12 | Upgrade
|
| Total Current Liabilities | 3.36 | 13.04 | 7.83 | 5.79 | 3.36 | Upgrade
|
| Long-Term Leases | 0.12 | 0.24 | 0.47 | 0.62 | 0.75 | Upgrade
|
| Other Long-Term Liabilities | 0.11 | 0.11 | 0.08 | 0.11 | - | Upgrade
|
| Total Liabilities | 3.58 | 13.39 | 8.38 | 6.52 | 4.18 | Upgrade
|
| Common Stock | 238.11 | 209.83 | 147.19 | 146.99 | 145.87 | Upgrade
|
| Retained Earnings | -220.73 | -163.51 | -114.02 | -75.23 | -41.27 | Upgrade
|
| Comprehensive Income & Other | 6.42 | 7.36 | 9.13 | 6.51 | 3.59 | Upgrade
|
| Shareholders' Equity | 23.81 | 53.68 | 42.31 | 78.27 | 108.18 | Upgrade
|
| Total Liabilities & Equity | 27.39 | 67.07 | 50.69 | 84.79 | 112.36 | Upgrade
|
| Total Debt | 0.24 | 0.34 | 0.62 | 0.75 | 0.91 | Upgrade
|
| Net Cash (Debt) | 17.63 | 56.04 | 39.1 | 70.33 | 103.76 | Upgrade
|
| Net Cash Growth | -68.54% | 43.30% | -44.40% | -32.22% | 31.67% | Upgrade
|
| Net Cash Per Share | 0.06 | 0.22 | 0.17 | 0.31 | 0.52 | Upgrade
|
| Filing Date Shares Outstanding | 350.36 | 281.76 | 234.25 | 229.91 | 226.96 | Upgrade
|
| Total Common Shares Outstanding | 350.36 | 281.76 | 232.68 | 229.91 | 224.75 | Upgrade
|
| Working Capital | 20.89 | 50.74 | 39.34 | 75.18 | 105.01 | Upgrade
|
| Book Value Per Share | 0.07 | 0.19 | 0.18 | 0.34 | 0.48 | Upgrade
|
| Tangible Book Value | 20.86 | 50.73 | 39.37 | 75.33 | 105.23 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.18 | 0.17 | 0.33 | 0.47 | Upgrade
|
| Machinery | 0.19 | 0.19 | 0.19 | 0.19 | 0.16 | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.